KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 60 filers reported holding KINNATE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.76 and the average weighting 0.4%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MARSHALL WACE, LLP | 84,148 | $117,806 | 0.00% |
| JPMORGAN CHASE & CO | 8,874 | $12,424 | 0.00% |
| Leucadia National | 37,500 | $52,500 | 0.00% |
| BARCLAYS PLC | 14,568 | $21 | 0.00% |
| ROYAL BANK OF CANADA | 26 | $0 | 0.00% |
| D. E. Shaw & Co., Inc. | 55,810 | $78,134 | 0.00% |
| VANGUARD GROUP INC | 994,212 | $1,391,897 | 0.00% |
| FEDERATED HERMES, INC. | 1,708 | $2,391 | 0.00% |
| JANE STREET GROUP, LLC | 24,515 | $34,321 | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 52,168 | $73,035 | 0.00% |
| Capital Advisors, Ltd. LLC | 197 | $0 | 0.00% |
| Cubist Systematic Strategies, LLC | 43,716 | $61,202 | 0.00% |
| Point72 Asset Management, L.P. | 1 | $1 | 0.00% |
| RHUMBLINE ADVISERS | 2,933 | $4,106 | 0.00% |
| Man Group plc | 97,472 | $136,461 | 0.00% |
| Squarepoint Ops LLC | 76,049 | $106,469 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 12,249 | $17,115 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 8,048 | $11,267 | 0.00% |
| WELLS FARGO & COMPANY/MN | 134 | $188 | 0.00% |
| NORTHERN TRUST CORP | 27,778 | $38,889 | 0.00% |
External links
This page lists KINNATE BIOPHARMA INC's shareholders in Q3 2023. To view KINNATE BIOPHARMA INC's shareholder history, click here.